bination of these factors. We have previously shown that experimental lactic acidosis secondary to phenformin administration could be prevented or reversed by administration of dichloroacetate (Holloway & Alberti, 1975) . This compound is an activator of pyruvate dehydrogenase (Whitehouse et al., 1974) has a weak hypoglycaemic action (Lorini & Ciman, 1962) , and also lowers blood lactate concentration in normal and diabetic rats (Blackshear et al., 1974 (Blackshear et al., , 1975 .
In the present study we have further investigated the hypolactataemic action of dichloroacetate, this time using a model for liver disease. The administration of D-(+)-galactosamine to the rat results in morphological changes in the liver which resemble human viral hepatitis. Peak effects are observed after 24 to 48h. Amongst the biochemical changes associated with this form of hepatitis are increased concentrations of serum bilirubin, and aspartate aminotransferase, and alanine aminotransferase (Keppler et al., 1968) together with decreased hepatic activities of these enzymes as well as of phosphoenolpyruvate carboxykinase (Record et al., 1972) . Galactosamineadministration also results in hyperlactataemia in the whole rat, although perfused livers from these animals show impaired gluconeogenesis from lactate (Record et al., 1972) .
In a second study we have infused fructose into animals with galactosamine induced hepatitis, since fructose administration into humans with liver disease causes a profound increase of blood lactate concentrations (Woods & Alberti, 1972) .
The experimental details are as described by Blackshear et al. (1974) . Rats were anaesthetised with an intraperitoneal injection of sodium phenobarbitone (60mg/kg body wt.) and cannulae placed in the left femoral artery and vein. They were then placed in restraining cages and given galactosamine (1 g/kg body wt.) as a neutral solution through the venous cannula. After 24h food deprivation a basal arterial blood sample was taken and NaCl(9g/l) or dichloroacetate infused at a rate of 1 ml/h for 120 min. In certain experiments the infusion was preceded by an intravenous bolus of fructose (I g/kg body wt.). Arterial blood samples were taken at frequent intervals and analysed for lactate, glucose, acetoacetate and 3-hydroxybutytate as previously described (Blackshear et al., 1974) .
Galactosamine administration resulted in a mild increase in blood lactate concentration (Table l) , although glucose ,concentration in unfed animals was unchanged (Table 2) , as previously noted by Record et al. (1972) . These authors also found decreased blood ketone body concentrations after galactosamine administration, aresult not found in the present study(Table2). The hyperlactataemia could well have been due to decreased phosphoenolpyruvate carboxykinase activity in the liver after galactosamine treatment (Record et al., 1972) , although frank hypoglycaemia was not present (Table 2) .
Dichloroacetate infusion into galactosamine-treated rats had effects similar to those observed by Blackshear et al. (1974) in normal rats deprived of food for 24h. Blood lactate and glucose concentrations were decreased with lactate concentrations lower even than in the control animals. It has been postulated previously that dichloroacetate acts primarily through inhibition of extrahepatic release of gluconeogenic precursors (Blackshear et a/., 1974) , which would agree with the present observations. Blood ketone body concentration was increased, which may have been due to inhibition of 3-hydroxybutyrate uptake by extrahepatic tissues (Blackshear et al., 1974) and VOl. 5 Table 1 . Effects of galuctosamine, fructose and dichloroacetate on blood lactate concentrations in r Rats were given 1 g of galactosamine/kg body wt. 24h before the infusion of NaCl (9g/l) or dichlor Fructose injection into galactosamine-treated rats resulted in a marked increase in blood lactate concentration (Table I) , an increase in blood glucose concentration (Table  2 ) and a dramatic decrease in blood ketone-body concentrations (Table 2) when compared with galactosamine-treated control rats. These results are similar to those reported by Rawat & Menahan (1975) , who injected fructose into normal rats. Dichloroacetate lowered the initial fructose-induced peak in blood lactate concentration (Table 1) and this rapidly decreased towards normal values. The hyperglycaemia and hypoketonaemia ( Table 2 ) that resulted from fructose injection were also reversed. These findings are consistent with our earlier observation that dichloroacetate decreases extrahepatic lactate production and increases ketogenesis from fructose in the isolated perfused rat liver (Johnson & Man, 1975) .
The results show that dichloroacetate brings about metabolic changes in galactosamine-treated rats that resemble those reported in normal rats deprived of food for 24 h. Dichloroacetate reverses the hyperlactataemia that results from galactosamine administration to the rat, and also counteracts the effects of fructose infusion. The effects may be explained by activation of pyruvate dehydrogenase both extrahepatically and in the liver. Dichloroacetate could well have a role as a therapeutic agent in clinical hyperlactataemic states.
